Fatality Related to a 30-g Venlafaxine Overdose

Pharmacotherapy

Volumn 23, Issue 12 I, 2003, Pages 1668-1672

  Mazur, Joseph E ^a   Doty, John D ^a   Krygiel, Ashley S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Metabolism; Overdose; Pharmacokinetics; Venlafaxine

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CITALOPRAM; COCODAMOL; CODEINE PHOSPHATE; DESVENLAFAXINE; DIPHENHYDRAMINE; DOBUTAMINE; DOPAMINE; GLICLAZIDE; LAMOTRIGINE; LIDOCAINE; LITHIUM CARBONATE; METFORMIN; MILRINONE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; NORTRIPTYLINE; PARACETAMOL; PHENYLEPHRINE; SALICYLIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TIOTIXENE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; CONSCIOUSNESS DISORDER; DRUG FATALITY; DRUG INTOXICATION; DRUG METABOLISM; DRUG OVERDOSE; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPOTENSION; INTESTINE ISCHEMIA; INTESTINE MOTILITY; INTESTINE PERFORATION; SEIZURE; TACHYCARDIA;

ADULT; CYCLOHEXANOLS; FATAL OUTCOME; FEMALE; HUMANS; OVERDOSE; SEROTONIN UPTAKE INHIBITORS;

EID: 0344011132     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.15.1668.31951     Document Type: Article

References (23)

1. Parsons AT, Anthony RM, Meeker JE. Two fatal cases of venlafaxine poisoning. J Anal Tox 1996;20:266-8.
2. Blythe D, Hackett LP. Cardiovascular and neurological toxicity of venlafaxine. Hum Exper Toxicol 1999;18:309-13.
3. Raja M, Azzoni A. Mirtazapine overdose with benign outcome. Eur Psychiatry 2002;17:107-17.
4. Benson MG, Kelley TR. Bupropion exposures: clinical manifestations and medical outcome. J Emerg Med 2002;23(3):223-30.
5. Druteika D, Zed PJ. Cardiotoxicity following bupropion overdose. Ann Pharmacother 2002;36:1791-5.
6. Benson BE, Mathiason M, Dahl B, et al. Toxicities and outcomes associated with nefazodone poisoning: an analysis of 1338 exposures. Am J Emerg Med 2000;18(5):587-92.
7. Fantaskey A, Burkhart KK. A case report of venlafaxine toxicity. J Toxicol Clin Toxicol 1995;33:359-61.
8. Banhaam NDG. Fatal venlafaxine overdose [letter]. Med J Austr 1998;169(8):445, 448.
9. Peano C, Leikin J, Hanashiro P. Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med 1997;30(5): 704-8.
10. Dahl B, Crouch BI, Rollins D. Death from venlafaxine overdose (Effexor) [abstr]. J Toxicol Clin Toxicol 1996;34:557.
11. Buckley NA, McManus PR. Fatal toxicity of serotonergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002;325:1332-3.
12. Wyeth-Ayerst Laboratories. Effexor XR (venlafaxine) package insert. Philadelphia, PA; 2002.
13. Klamerus KJ, Maloney K, Rudolph RL, Sisenwine SF, Jusko WJ, Chiang ST. Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite. J Clin Pharmacol 1992;32:716-24.
14. Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol 1997;17(suppl 1):2S-18.
15. Feighner JP. Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry 1995;56:574-9.
16. Rudolph RL, Derivan AT. The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database. J Clin Psychopharmacol 1996;16(suppl 2):54S-9.
17. Brower KL, Dukes GE, Powell JR. Influence of liver function on drug disposition. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics, 3rd ed. Vancouver, WA.: Applied Therapeutics, 1992:6.1-6.59.
18. Sporer KA, Manning JJ. Massive ingestion of sustained-release verapamil with a concretion and bowel infarction. Ann Emerg Med 1993;2:603-5.
19. Long C, Crifasi J, Maginn D, Graham M, Teas S. Comparison of analytical methods in the determination of two venlafaxine fatalities. J Ann Toxicol 1997;21:166-9.
20. Jaffe PD, Batziris HP, van der Hoeven P, DeSilva D, McIntyre IM. A study involving venlafaxine overdoses: comparison of fatal and therapeutic concentrations in postmortem specimens. J Forensic Sci 1999;44(1):193-6.
21. Koken L, Dart RC. Life-threatening hypotension from venlafaxine overdose [abstr]. J Toxicol Clin Toxicol 1996;34:559.
22. Oliver JJ, Kelly C, Jarvie D, Denieul S, Bateman DN. Venlafaxine poisoning complicated by a late rise in creatinine kinase: two case reports. Hum Exper Toxicol 2002;21:463-6.
23. Levine B, Jenkins AJ, Queen M, Jufer R, Smialek JF. Distribution of venlafaxine in three postmortem cases. J Anal Toxicol 1996;20:502-5.